MIR2116

Across TCGA pan-cancer cohorts, MIR2116 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR2116’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR2116 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR2116 is over-expressed in tumor.

LUSC, BLCA, and KIRP are the cancer types where MIR2116 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR2116 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.438	.001	7	view →
BLCA	All	All	+0.740	.001	5	view →
KIRP	All	IV	+0.645	.025	4	view →
HNSC	All	All	+0.335	.003	4	view →
STAD	All	All	+0.562	.017	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR2116–LUSC

Open the LUSC breakdown →